Recommendation 5.4 To encourage private-sector product development, the global market for tuberculosis diagnostic tests, drugs, and vaccines should be better characterized and access to these markets for these new products should be facilitated.

Recommendation 5.5 To define the applicability of any new tools to the international arena and facilitate their development, the U.S. Agency for International Development (AID), NIH, and CDC should build upon international relationships and expertise to conduct research.

Recommendation 6.1 To decrease the number of foreign-born individuals with tuberculosis in the United States, to minimize the spread and impact of multidrug-resistant tuberculosis, and to improve global health, the committee recommends that

  • The United States expand and strengthen its role in global tuberculosis control efforts, contributing to these efforts in a substantial manner through bilateral and multilateral international efforts.

  • The United States contribute to global tuberculosis control efforts through targeted use of financial, technical, and human resources and research, all guided by a carefully considered strategic plan.

  • The United States work in close coordination with other government and international agencies. In particular, the United States should continue its active role in and support of the Stop TB Initiative.

  • AID, CDC, and NIH should jointly develop and publish strategic plans to guide U.S. involvement in global tuberculosis control efforts.

Recommendation 7.1 To build public support and sustain public interest and commitment to the elimination of tuberculosis, the committee recommends that CDC significantly increase resources for activities to secure and sustain public understanding and support for tuberculosis elimination efforts at the national, state, and local levels, including programs to increase knowledge among targeted groups of the general public.

Recommendation 7.2 To increase the effectiveness of mobilization efforts the committee recommends that the National Coalition for the Elimination of Tuberculosis continue to provide leadership and oversight and that CDC continue to work in collaboration with the coalition to secure the support and participation of nontraditional public health partners, ensure the development of state and local coalitions, and evaluate public understanding and support for tuberculosis elimination efforts with the assistance of public opinion research experts.

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement